Clearance Summary
NOVOPEN SYSTEM (INSULIN SYRINGE) received FDA 510(k) clearance under submission number K861686, sponsored by Squibb-Novo, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 1987-01-21.
- Submission: K861686
- Applicant / Sponsor: Squibb-Novo, Inc.
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5860
- Decision date: 1987-01-21
Classification & Regulation
This clearance is catalogued under FDA product code FMF and 21 CFR 880.5860, within the General Hospital review panel as a Class II device.